Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

August 01, 1995; Volume 23,Issue 8
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ader, J C

    1. You have access
      Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;
  2. Aigbirhio, F I

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;
  3. Ali, S F

    1. You have access
      Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;
  4. Anders, M W

    1. You have access
      Gas-uptake pharmacokinetics and metabolism of 2-chloro-1,1,1,2-tetrafluoroethane (HCFC-124) in the rat, mouse, and hamster.
      G D Loizou and M W Anders
      Drug Metabolism and Disposition August 1995, 23 (8) 875-880;
  5. Anderson, K

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

B

  1. Benet, L Z

    1. You have access
      Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;
  2. Binienda, Z

    1. You have access
      Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;
  3. Birner, G

    1. You have access
      The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
      M Werner, G Birner and W Dekant
      Drug Metabolism and Disposition August 1995, 23 (8) 861-868;
  4. Blake, T

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;
  5. Bornheim, L M

    1. You have access
      Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;

C

  1. Cheng, L K

    1. You have access
      Human metabolism of dolasetron mesylate, a 5-HT3 receptor antagonist.
      M K Reith, G D Sproles and L K Cheng
      Drug Metabolism and Disposition August 1995, 23 (8) 806-812;
  2. Cho, J H

    1. You have access
      In vivo modification of 3'-phosphoadenosine 5'-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine.
      H J Kim, C Madhu, J H Cho and C D Klaassen
      Drug Metabolism and Disposition August 1995, 23 (8) 840-845;
  3. Chouini-Lalanne, N

    1. You have access
      Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;
  4. Crowley, J R

    1. You have access
      Mechanism-based inactivation of rat liver cytochrome P4502B1 by phencyclidine and its oxidative product, the iminium ion.
      J R Crowley and P F Hollenberg
      Drug Metabolism and Disposition August 1995, 23 (8) 786-793;

D

  1. Dekant, W

    1. You have access
      The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
      M Werner, G Birner and W Dekant
      Drug Metabolism and Disposition August 1995, 23 (8) 861-868;
  2. Dreyer, G

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;
  3. Duescher, R J

    1. You have access
      Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;

E

  1. Elfarra, A A

    1. You have access
      Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;

F

  1. Facchine, K L

    1. You have access
      An improved HPLC assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin.
      J S Walsh, J E Patanella, K A Halm and K L Facchine
      Drug Metabolism and Disposition August 1995, 23 (8) 869-874;
  2. Fong, K L

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;
  3. Freemantle, C A

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;
  4. Fukuyama, T

    1. You have access
      Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
      H Yasui, K Yamaoka, T Fukuyama and T Nakagawa
      Drug Metabolism and Disposition August 1995, 23 (8) 779-785;

G

  1. Garver, E

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;
  2. Gilard, V

    1. You have access
      Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;

H

  1. Halm, K A

    1. You have access
      An improved HPLC assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin.
      J S Walsh, J E Patanella, K A Halm and K L Facchine
      Drug Metabolism and Disposition August 1995, 23 (8) 869-874;
  2. Heys, R

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;
  3. Hollenberg, P F

    1. You have access
      Mechanism-based inactivation of rat liver cytochrome P4502B1 by phencyclidine and its oxidative product, the iminium ion.
      J R Crowley and P F Hollenberg
      Drug Metabolism and Disposition August 1995, 23 (8) 786-793;

J

  1. Jones, T

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;
  2. Joseph, G

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;

K

  1. Kim, H

    1. You have access
      3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue.
      H Kim, S Reddy and R F Novak
      Drug Metabolism and Disposition August 1995, 23 (8) 818-824;
  2. Kim, H J

    1. You have access
      In vivo modification of 3'-phosphoadenosine 5'-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine.
      H J Kim, C Madhu, J H Cho and C D Klaassen
      Drug Metabolism and Disposition August 1995, 23 (8) 840-845;
  3. Kim, K Y

    1. You have access
      Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;
  4. Klaassen, C D

    1. You have access
      In vivo modification of 3'-phosphoadenosine 5'-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine.
      H J Kim, C Madhu, J H Cho and C D Klaassen
      Drug Metabolism and Disposition August 1995, 23 (8) 840-845;

L

  1. Lash, L H

    1. You have access
      Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;
  2. Li, J

    1. You have access
      Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;
  3. Lipe, G

    1. You have access
      Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;
  4. Loizou, G D

    1. You have access
      Gas-uptake pharmacokinetics and metabolism of 2-chloro-1,1,1,2-tetrafluoroethane (HCFC-124) in the rat, mouse, and hamster.
      G D Loizou and M W Anders
      Drug Metabolism and Disposition August 1995, 23 (8) 875-880;

M

  1. Macleod, M C

    1. You have access
      Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;
  2. Madhu, C

    1. You have access
      In vivo modification of 3'-phosphoadenosine 5'-phosphosulfate and sulfate by infusion of sodium sulfate, cysteine, and methionine.
      H J Kim, C Madhu, J H Cho and C D Klaassen
      Drug Metabolism and Disposition August 1995, 23 (8) 840-845;
  3. Malet-Martino, M C

    1. You have access
      Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;
  4. Martino, R

    1. You have access
      Structural determination of a glucuronide conjugate of flucytosine in humans.
      N Chouini-Lalanne, M C Malet-Martino, V Gilard, J C Ader and R Martino
      Drug Metabolism and Disposition August 1995, 23 (8) 813-817;

N

  1. Nakagawa, T

    1. You have access
      Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
      H Yasui, K Yamaoka, T Fukuyama and T Nakagawa
      Drug Metabolism and Disposition August 1995, 23 (8) 779-785;
  2. Novak, R F

    1. You have access
      3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue.
      H Kim, S Reddy and R F Novak
      Drug Metabolism and Disposition August 1995, 23 (8) 818-824;

O

  1. Olsson, P

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

P

  1. Page, B C

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;
  2. Parker, J C

    1. You have access
      Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;
  3. Parker, W B

    1. You have access
      Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;
  4. Patanella, J E

    1. You have access
      An improved HPLC assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin.
      J S Walsh, J E Patanella, K A Halm and K L Facchine
      Drug Metabolism and Disposition August 1995, 23 (8) 869-874;
  5. Perotti, B Y

    1. You have access
      Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
      L M Bornheim, K Y Kim, J Li, B Y Perotti and L Z Benet
      Drug Metabolism and Disposition August 1995, 23 (8) 825-831;
  6. Pike, V W

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;
  7. Potts, W

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;
  8. Powell, K L

    1. You have access
      Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;

Q

  1. Qing, W G

    1. You have access
      Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;

R

  1. Reddy, S

    1. You have access
      3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue.
      H Kim, S Reddy and R F Novak
      Drug Metabolism and Disposition August 1995, 23 (8) 818-824;
  2. Reith, M K

    1. You have access
      Human metabolism of dolasetron mesylate, a 5-HT3 receptor antagonist.
      M K Reith, G D Sproles and L K Cheng
      Drug Metabolism and Disposition August 1995, 23 (8) 806-812;
  3. Rhodes, C G

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;
  4. Rose, L M

    1. You have access
      Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;

S

  1. Sandberg, J A

    1. You have access
      Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;
  2. Semple, H A

    1. You have access
      Interaction between propranolol and amino acids in the single-pass isolated, perfused rat liver.
      H A Semple and F Xia
      Drug Metabolism and Disposition August 1995, 23 (8) 794-798;
  3. Shu, A

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;
  4. Slikker, W

    1. You have access
      Placental transfer and fetal disposition of 2',3'-dideoxycytidine and 2',3'-dideoxyinosine in the rhesus monkey.
      J A Sandberg, Z Binienda, G Lipe, L M Rose, W B Parker, S F Ali and W Slikker
      Drug Metabolism and Disposition August 1995, 23 (8) 881-884;
  5. Sproles, G D

    1. You have access
      Human metabolism of dolasetron mesylate, a 5-HT3 receptor antagonist.
      M K Reith, G D Sproles and L K Cheng
      Drug Metabolism and Disposition August 1995, 23 (8) 806-812;
  6. Stoica, G

    1. You have access
      Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;
  7. Szumlanski, C L

    1. You have access
      Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;

T

  1. Tanner, R J

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

V

  1. van Horn, R

    1. You have access
      Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
      W Potts, R van Horn, K Anderson, T Blake, E Garver, G Joseph, G Dreyer, A Shu, R Heys and K L Fong
      Drug Metabolism and Disposition August 1995, 23 (8) 799-805;
  2. Ventresca, G P

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;

W

  1. Walsh, J S

    1. You have access
      An improved HPLC assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin.
      J S Walsh, J E Patanella, K A Halm and K L Facchine
      Drug Metabolism and Disposition August 1995, 23 (8) 869-874;
  2. Waters, S L

    1. You have access
      Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.
      V W Pike, F I Aigbirhio, C A Freemantle, B C Page, C G Rhodes, S L Waters, T Jones, P Olsson, G P Ventresca and R J Tanner
      Drug Metabolism and Disposition August 1995, 23 (8) 832-839;
  3. Weinshilboum, R M

    1. You have access
      Toxicity and metabolism in mice of 2,6-dithiopurine, a potential chemopreventive agent.
      W G Qing, K L Powell, G Stoica, C L Szumlanski, R M Weinshilboum and M C Macleod
      Drug Metabolism and Disposition August 1995, 23 (8) 854-860;
  4. Werner, M

    1. You have access
      The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
      M Werner, G Birner and W Dekant
      Drug Metabolism and Disposition August 1995, 23 (8) 861-868;

X

  1. Xia, F

    1. You have access
      Interaction between propranolol and amino acids in the single-pass isolated, perfused rat liver.
      H A Semple and F Xia
      Drug Metabolism and Disposition August 1995, 23 (8) 794-798;
  2. Xu, Y

    1. You have access
      Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity.
      L H Lash, Y Xu, A A Elfarra, R J Duescher and J C Parker
      Drug Metabolism and Disposition August 1995, 23 (8) 846-853;

Y

  1. Yamaoka, K

    1. You have access
      Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
      H Yasui, K Yamaoka, T Fukuyama and T Nakagawa
      Drug Metabolism and Disposition August 1995, 23 (8) 779-785;
  2. Yasui, H

    1. You have access
      Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
      H Yasui, K Yamaoka, T Fukuyama and T Nakagawa
      Drug Metabolism and Disposition August 1995, 23 (8) 779-785;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 23, Issue 8
1 Aug 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Metabolism and Disposition of Volanesorsen across Species
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics